Table 1 Summary of study characteristics
Characteristic | Number (% out of 62) |
|---|---|
Year of publication | |
 1979 to 1986 | 5 (8 %) |
 1987 to 1994 | 2 (3 %) |
 1995 to 2002 | 15 (24 %) |
 2003 to 2010 | 32 (52 %) |
 2011 | 4 (6 %) |
 2012 | 4 (6 %) |
Study period | |
 1970 to 1980 | 4 (6 %) |
 1981 to 1990 | 3 (5 %) |
 1991 to 2000 | 21 (34 %) |
 2001 to 2010 | 17 (27 %) |
 Not reported | 17 (27 %) |
Geographic region of conduct | |
 North America | 39 (63 %) |
 Europe | 16 (26 %) |
 Australia | 4 (6 %) |
 Asia | 2 (3 %) |
 South America | 1 (2 %) |
Study design | |
 Randomized controlled trial | 31 (50 %) |
 Cohort | 24 (39 %) |
 Cluster-randomized controlled trial | 2 (3 %) |
 Non-randomized controlled trial | 2 (3 %) |
 Case control | 1 (2 %) |
 Controlled before-after study | 1 (2 %) |
 Quasi-randomized controlled trial | 1 (2 %) |
Funding sources | |
 Not reported | 19 (24 %) |
 Governmental organization | 18 (23 %) |
 Research funding body | 16 (21 %) |
 Commercial organization | 11 (14 %) |
 Healthcare provider organization | 6 (8 %) |
 Charitable trust | 3 (4 %) |
 Voluntary body | 2 (3 %) |
 Mixed | 2 (3 %) |
 Other | 1 (1 %) |
Duration of knowledge translation intervention (in weeks) | |
 61 to 104 | 38 (61 %) |
 104 to 157 | 10 (16 %) |
 157 to 209 | 4 (6 %) |
 209 to 261 | 3 (5 %) |
 261 to 313 | 0 (0 %) |
 313 to 365 | 1 (2 %) |
 365 to 417 | 1 (2 %) |
 417 to 470 | 0 (0 %) |
 470 to 522 | 5 (8 %) |
Setting | |
 Multi-site | 36 (58 %) |
 Single-site | 25 (40 %) |
 Not reported | 1 (2 %) |
Number of study arms | |
 2 | 51 (82 %) |
 3 | 4 (6 %) |
 4 | 6 (10 %) |
 8 | 1 (2 %) |
Follow-up duration in weeks | |
 52 to 104 | 34 (55 %) |
 104 to 157 | 11 (18 %) |
 157 to 209 | 5 (8 %) |
 209 to 261 | 4 (6 %) |
 261 to 313 | 0 (0 %) |
 313 to 365 | 1 (2 %) |
 365 to 417 | 1 (2 %) |
 417 to 470 | 0 (0 %) |
 470 to 522 | 5 (8 %) |
 Not reported | 1 (2 %) |